A stock Yokohama bioresearch and supply (henceforth, YBRS),
It is the venture business launched in Yokohama in August, 2006 for the purpose of doing research etc. to which charge is manufacture-taken and the gene recombination protein bulk drug with which research aiming at drug development, various examinations, a clinical trial, etc. are presented relates.
Management and management of the bio-Investigational Product GMP manufacturing facilities Yokohama biomedicine Development Center” newly built in Yokohama are left to YBRS.